Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of aripiprazole oral solution in adult inpatients with acute schizophrenia
ChiCTR2100046541Phase 4Recruiting
- Sponsor
- Beijing Anding Hospital
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aripiprazole in schizophrenia, sponsored by Beijing Anding Hospital. Primary endpoint: Change in PANSS total score from baseline at study endpoint. Started May 2021; status: recruiting.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ChiCTR2100046541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046541.